DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
TARLOXOTINIB BROMIDE
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung
Unknown
TARLOXOTINIB BROMIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
3Y31FJ8K50
Molecule Type:
Small molecule
Molecular Formula:
C24H24Br2ClN9O3
Molecular Weight:
681.78
AlogP:
4.6
PSA:
140.76
HBD:
2.0
HBA:
#RotB:
9.0
Source:
FASITIBANT CHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Bradykinin B2 receptor antagonist
FASITIBANT CHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
7J764K70IG
Molecule Type:
Small molecule
Molecular Formula:
C36H49Cl3N6O6S
Molecular Weight:
800.25
AlogP:
4.05
PSA:
144.16
HBD:
2.0
HBA:
#RotB:
12.0
Source:
AFACIFENACIN
2
Small molecule
Investigational
Unknown
Unknown
Urinary Bladder, Overactive
Muscarinic acetylcholine receptor antagonist
AFACIFENACIN
×
Maximum Phase:
2
First Approval:
None
UNII:
XQU62QZ74P
Molecule Type:
Small molecule
Molecular Formula:
C27H26F3N3O2
Molecular Weight:
481.52
AlogP:
6.19
PSA:
44.81
HBD:
1.0
HBA:
#RotB:
5.0
Source:
SSR180711
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease
Neuronal acetylcholine receptor protein alpha-7 subunit partial agonist
SSR180711
×
Maximum Phase:
2
First Approval:
None
UNII:
QF4P1U1666
Molecule Type:
Small molecule
Molecular Formula:
C14H17BrN2O2
Molecular Weight:
325.21
AlogP:
2.73
PSA:
32.78
HBD:
0.0
HBA:
#RotB:
1.0
Source:
COFORMYCIN
2
Small molecule
Investigational
Unknown
Unknown
Leukemia
Adenosine deaminase inhibitor
COFORMYCIN
×
Maximum Phase:
2
First Approval:
None
UNII:
E49510ZL0H
Molecule Type:
Small molecule
Molecular Formula:
C11H16N4O5
Molecular Weight:
284.27
AlogP:
-2.21
PSA:
132.36
HBD:
5.0
HBA:
#RotB:
2.0
Source:
CXA-10
2
Small molecule
Investigational
Unknown
Unknown
Acute Kidney Injury; Asthma; Glomerulosclerosis, Focal Segmental; Hypertension, Pulmonary
Unknown
CXA-10
×
Maximum Phase:
2
First Approval:
None
UNII:
1N19AGY57Y
Molecule Type:
Small molecule
Molecular Formula:
C18H33NO4
Molecular Weight:
327.46
AlogP:
5.71
PSA:
80.44
HBD:
1.0
HBA:
#RotB:
16.0
Source:
TENATOPRAZOLE
2
Small molecule
Investigational
Unknown
Unknown
Esophagitis, Peptic
Unknown
TENATOPRAZOLE
×
Maximum Phase:
2
First Approval:
None
UNII:
RE0689TX2K
Molecule Type:
Small molecule
Molecular Formula:
C16H18N4O3S
Molecular Weight:
346.41
AlogP:
2.29
PSA:
89.99
HBD:
1.0
HBA:
#RotB:
5.0
Source:
MOSEDIPIMOD
2
Small molecule
Investigational
Unknown
Unknown
Inflammation; Neoplasms; Neutropenia; Severe Acute Respiratory Syndrome; Stomatitis
Unknown
MOSEDIPIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
88928BS57E
Molecule Type:
Small molecule
Molecular Formula:
C39H70O6
Molecular Weight:
634.98
AlogP:
11.3
PSA:
78.9
HBD:
0.0
HBA:
#RotB:
33.0
Source:
BI-671800
2
Small molecule
Investigational
Unknown
Unknown
Asthma
G protein-coupled receptor 44 antagonist
BI-671800
×
Maximum Phase:
2
First Approval:
None
UNII:
721F767LHB
Molecule Type:
Small molecule
Molecular Formula:
C25H26F3N5O3
Molecular Weight:
501.51
AlogP:
4.1
PSA:
98.66
HBD:
2.0
HBA:
#RotB:
8.0
Source:
SPH-3127
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
SPH-3127
×
Maximum Phase:
2
First Approval:
None
UNII:
C2M78A9V6Z
Molecule Type:
Small molecule
Molecular Formula:
C22H32N6O4
Molecular Weight:
444.54
AlogP:
1.53
PSA:
110.61
HBD:
2.0
HBA:
#RotB:
8.0
Source:
IPI-549
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
IPI-549
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CALDARET MONOHYDRATE
2
Small molecule
Investigational
Unknown
Unknown
Heart Failure; Myocardial Infarction
Unknown
CALDARET MONOHYDRATE
×
Maximum Phase:
2
First Approval:
None
UNII:
2SH110E854
Molecule Type:
Small molecule
Molecular Formula:
C11H18N2O4S
Molecular Weight:
274.34
AlogP:
0.65
PSA:
69.64
HBD:
2.0
HBA:
#RotB:
2.0
Source:
PF-03635659
2
Small molecule
Investigational
Unknown
Unknown
Pulmonary Disease, Chronic Obstructive
Unknown
PF-03635659
×
Maximum Phase:
2
First Approval:
None
UNII:
O0RG3QM34H
Molecule Type:
Small molecule
Molecular Formula:
C28H32N2O3
Molecular Weight:
444.58
AlogP:
4.49
PSA:
75.79
HBD:
2.0
HBA:
#RotB:
9.0
Source:
S-777469
2
Small molecule
Investigational
Unknown
Unknown
Dermatitis, Atopic
Cannabinoid CB2 receptor agonist
S-777469
×
Maximum Phase:
2
First Approval:
None
UNII:
88NI79737I
Molecule Type:
Small molecule
Molecular Formula:
C23H27FN2O4
Molecular Weight:
414.48
AlogP:
3.42
PSA:
88.4
HBD:
2.0
HBA:
#RotB:
6.0
Source:
NEVANIMIBE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Acyl coenzyme A:cholesterol acyltransferase 1 inhibitor
NEVANIMIBE
×
Maximum Phase:
2
First Approval:
None
UNII:
VK9OS8R205
Molecule Type:
Small molecule
Molecular Formula:
C27H39N3O
Molecular Weight:
421.63
AlogP:
6.63
PSA:
44.37
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PERFLUORO TERT-BUTYLCYCLOHEXANE
2
Small molecule
Investigational
Unknown
Unknown
Brain Injuries
Unknown
PERFLUORO TERT-BUTYLCYCLOHEXANE
×
Maximum Phase:
2
First Approval:
None
UNII:
3ZX1Z33VUU
Molecule Type:
Small molecule
Molecular Formula:
C10F20
Molecular Weight:
500.07
AlogP:
6.56
PSA:
0.0
HBD:
0.0
HBA:
#RotB:
1.0
Source:
2-IMINOBIOTIN
2
Small molecule
Investigational
Unknown
Unknown
Hypoxia-Ischemia, Brain
Unknown
2-IMINOBIOTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
HXH71NRQ5C
Molecule Type:
Small molecule
Molecular Formula:
C10H17N3O2S
Molecular Weight:
243.33
AlogP:
0.61
PSA:
85.21
HBD:
4.0
HBA:
#RotB:
5.0
Source:
X-82
2
Small molecule
Investigational
Unknown
Unknown
Adenocarcinoma; Neoplasms; Pancreatic Neoplasms; Macular Degeneration; Retinal Diseases
Platelet-derived growth factor receptor inhibitor
X-82
×
Maximum Phase:
2
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
NEBOGLAMINE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Glutamate [NMDA] receptor positive allosteric modulator
NEBOGLAMINE
×
Maximum Phase:
2
First Approval:
None
UNII:
12EA34U5B8
Molecule Type:
Small molecule
Molecular Formula:
C13H24N2O3
Molecular Weight:
256.35
AlogP:
1.26
PSA:
92.42
HBD:
3.0
HBA:
#RotB:
5.0
Source:
TARLOXOTINIB
2
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell
Epidermal growth factor receptor inhibitor
TARLOXOTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
H8768UL06V
Molecule Type:
Small molecule
Molecular Formula:
C24H24BrClN9O3+
Molecular Weight:
601.87
AlogP:
4.6
PSA:
140.76
HBD:
2.0
HBA:
#RotB:
9.0
Source:
VAFIDEMSTAT
2
Small molecule
Investigational
Unknown
Unknown
Alzheimer Disease; Borderline Personality Disorder
Unknown
VAFIDEMSTAT
×
Maximum Phase:
2
First Approval:
None
UNII:
LZ82JLT4UP
Molecule Type:
Small molecule
Molecular Formula:
C19H20N4O2
Molecular Weight:
336.4
AlogP:
2.88
PSA:
86.2
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PF-03715455
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Pulmonary Disease, Chronic Obstructive
MAP kinase p38 alpha inhibitor
PF-03715455
×
Maximum Phase:
2
First Approval:
None
UNII:
0TJ631J0KP
Molecule Type:
Small molecule
Molecular Formula:
C35H34ClN7O3S2
Molecular Weight:
700.29
AlogP:
7.8
PSA:
129.6
HBD:
4.0
HBA:
#RotB:
10.0
Source:
GSK2838232
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Unknown
GSK2838232
×
Maximum Phase:
2
First Approval:
None
UNII:
G9C7884M8M
Molecule Type:
Small molecule
Molecular Formula:
C48H73ClN2O6
Molecular Weight:
809.57
AlogP:
9.46
PSA:
107.38
HBD:
2.0
HBA:
#RotB:
13.0
Source:
EXEPORFINIUM CHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Staphylococcal Infections
Unknown
EXEPORFINIUM CHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
1912L54M2V
Molecule Type:
Small molecule
Molecular Formula:
C44H50Cl2N6O2
Molecular Weight:
765.83
AlogP:
8.94
PSA:
75.82
HBD:
2.0
HBA:
#RotB:
12.0
Source:
BIMOSIAMOSE
2
Small molecule
Investigational
Unknown
Unknown
Psoriasis; Pulmonary Disease, Chronic Obstructive
Selectin inhibitor
BIMOSIAMOSE
×
Maximum Phase:
2
First Approval:
None
UNII:
97B5KCW80W
Molecule Type:
Small molecule
Molecular Formula:
C46H54O16
Molecular Weight:
862.92
AlogP:
1.98
PSA:
273.36
HBD:
10.0
HBA:
#RotB:
19.0
Source:
POSELTINIB
2
Small molecule
Investigational
Unknown
Unknown
Arthritis, Rheumatoid
Tyrosine-protein kinase BTK inhibitor
POSELTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
D01E4B1U35
Molecule Type:
Small molecule
Molecular Formula:
C26H26N6O3
Molecular Weight:
470.53
AlogP:
4.64
PSA:
95.76
HBD:
2.0
HBA:
#RotB:
7.0
Source:
PSI-352938
2
Small molecule
Investigational
Unknown
Unknown
Hepatitis C; Hepatitis C, Chronic
RNA-directed RNA polymerase inhibitor
PSI-352938
×
Maximum Phase:
2
First Approval:
None
UNII:
3Z30JH9QX1
Molecule Type:
Small molecule
Molecular Formula:
C16H23FN5O6P
Molecular Weight:
431.36
AlogP:
2.38
PSA:
132.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
METHOXYAMINE
2
Small molecule
Investigational
Unknown
Unknown
Neoplasms; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Glioblastoma
Unknown
METHOXYAMINE
×
Maximum Phase:
2
First Approval:
None
UNII:
9TZH4WY30J
Molecule Type:
Small molecule
Molecular Formula:
CH5NO
Molecular Weight:
47.06
AlogP:
-0.49
PSA:
35.25
HBD:
1.0
HBA:
#RotB:
0.0
Source:
CARMEGLIPTIN
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Dipeptidyl peptidase IV inhibitor
CARMEGLIPTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
9Z723VGH7J
Molecule Type:
Small molecule
Molecular Formula:
C20H28FN3O3
Molecular Weight:
377.46
AlogP:
1.52
PSA:
68.03
HBD:
1.0
HBA:
#RotB:
4.0
Source:
LY-2608204
2
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Hexokinase type IV activator
LY-2608204
×
Maximum Phase:
2
First Approval:
None
UNII:
5A0L003HEY
Molecule Type:
Small molecule
Molecular Formula:
C28H37N3O3S3
Molecular Weight:
559.82
AlogP:
5.74
PSA:
79.37
HBD:
1.0
HBA:
#RotB:
10.0
Source:
ELZASONAN HYDROCHLORIDE
2
Small molecule
Investigational
Unknown
Unknown
Unknown
Serotonin 1b (5-HT1b) receptor antagonist
ELZASONAN HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
X38F62RR8L
Molecule Type:
Small molecule
Molecular Formula:
C22H24Cl3N3OS
Molecular Weight:
484.88
AlogP:
4.87
PSA:
26.79
HBD:
0.0
HBA:
#RotB:
3.0
Source:
PF-00610355
2
Small molecule
Investigational
Unknown
Unknown
Asthma; Lung Diseases; Pulmonary Disease, Chronic Obstructive
Beta-2 adrenergic receptor agonist
PF-00610355
×
Maximum Phase:
2
First Approval:
None
UNII:
ZH5SMU97AJ
Molecule Type:
Small molecule
Molecular Formula:
C34H39N3O6S
Molecular Weight:
617.77
AlogP:
4.64
PSA:
147.99
HBD:
6.0
HBA:
#RotB:
13.0
Source:
ABEPRAZAN
2
Small molecule
Investigational
Unknown
Unknown
Esophagitis, Peptic; Gastritis; Gastroesophageal Reflux; Peptic Ulcer
Potassium-transporting ATPase inhibitor
ABEPRAZAN
×
Maximum Phase:
2
First Approval:
None
UNII:
BE52S2C1QT
Molecule Type:
Small molecule
Molecular Formula:
C19H17F3N2O3S
Molecular Weight:
410.42
AlogP:
3.54
PSA:
60.33
HBD:
1.0
HBA:
#RotB:
6.0
Source:
DIFLOMOTECAN
2
Small molecule
Investigational
Unknown
Unknown
Small Cell Lung Carcinoma
DNA topoisomerase I inhibitor
DIFLOMOTECAN
×
Maximum Phase:
2
First Approval:
None
UNII:
QKT1LC4J1P
Molecule Type:
Small molecule
Molecular Formula:
C21H16F2N2O4
Molecular Weight:
398.37
AlogP:
2.75
PSA:
81.42
HBD:
1.0
HBA:
#RotB:
1.0
Source:
BMS-955176
2
Small molecule
Investigational
Unknown
Unknown
HIV Infections
Protease inhibitor
BMS-955176
×
Maximum Phase:
2
First Approval:
None
UNII:
4CA9IAU7RJ
Molecule Type:
Small molecule
Molecular Formula:
C42H62N2O4S
Molecular Weight:
691.03
AlogP:
8.11
PSA:
86.71
HBD:
2.0
HBA:
#RotB:
7.0
Source:
1
2
…
98
99
100
101
102
103
104
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA